Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

HB 336
New Mexico House•Introduced
Summary
HB 336, “Use Of Fda-approved Psilocybin”, was introduced in the House on Feb 4, 2026 by Rep. Dayan Hochman-Vigil (D). It last saw action on Feb 4, 2026: Action Postponed Indefinitely.
Record
Text
HB 336 has no co-sponsors and has not gone to a roll call.
hb336/introduced.txt1 HOUSE BILL 3362 57TH LEGISLATURE - STATE OF NEW MEXICO - SECOND SESSION, 20263 INTRODUCED BY4 Dayan Hochman-Vigil5678910 AN ACT11 RELATING TO CONTROLLED SUBSTANCES; PROVIDING FOR THE USE OF12 FEDERAL FOOD AND DRUG ADMINISTRATION-APPROVED SYNTHETIC13 PSILOCYBIN OR -APPROVED DRUGS THAT CONTAIN SYNTHETIC14 PSILOCYBIN.1516 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF NEW MEXICO:[bracketed material] = delete17 SECTION 1. Section 30-31-3 NMSA 1978 (being Laws 1972,underscored material = new18 Chapter 84, Section 3, as amended) is amended to read:19 "30-31-3. DUTY TO ADMINISTER.--20 A. The board shall administer the Controlled21 Substances Act and may add by [regulation] rule substances to22 the list of substances enumerated in Schedules I through IV23 pursuant to the procedures of the [Uniform Licensing] State24 Rules Act. In determining whether a substance has the25 potential for abuse, the board shall consider the following:.232205.11 (1) the actual or relative abuse of the2 substance;3 (2) the scientific evidence of the4 pharmacological effect of the substance, if known;5 (3) the state of current scientific knowledge6 regarding the substance;7 (4) the history and current pattern of abuse;8 (5) the scope, duration and significance of9 abuse;10 (6) the risk to the public health; and11 (7) the potential of the substance to produce12 psychic or physiological dependence liability.13 B. After considering the factors enumerated in14 Subsection A of this section, the board shall make findings and15 issue [regulations] rules controlling the substance if it finds16 the substance has a potential for abuse.[bracketed material] = delete17 C. If [any] a substance is designated as aunderscored material = new18 controlled substance under federal law and notice is given to19 the board, the board may, by [regulation] rule, similarly20 control the substance under the Controlled Substances Act after21 providing for a hearing pursuant to the [Uniform Licensing]22 State Rules Act.23 D. If the federal food and drug administration24 approves synthetic psilocybin or a drug containing synthetic25 psilocybin, synthetic psilocybin or the drug containing.232205.1- 2 -1 synthetic psilocybin shall be approved for use in New Mexico.2 [D.] E. Authority to control under this section3 does not extend to distilled spirits, wine, malt beverages,4 tobacco or pesticides as defined in the Pesticide Control Act."5 SECTION 2. Section 30-31-6 NMSA 1978 (being Laws 1972,6 Chapter 84, Section 6, as amended) is amended to read:7 "30-31-6. SCHEDULE I.--The following controlled8 substances are included in Schedule I:9 A. any of the following opiates, including their10 isomers, esters, ethers, salts and salts of isomers, esters and11 ethers, unless specifically exempted, whenever the existence of12 these isomers, esters, ethers and salts is possible within the13 specific chemical designation:14 (1) acetylmethadol;15 (2) allylprodine;16 (3) alphacetylmethadol;[bracketed material] = delete17 (4) alphameprodine;underscored material = new18 (5) alphamethadol;19 (6) benzethidine;20 (7) betacetylmethadol;21 (8) betameprodine;22 (9) betamethadol;23 (10) betaprodine;24 (11) clonitazene;25 (12) dextromoramide;.232205.1- 3 -1 (13) dextrorphan;2 (14) diampromide;3 (15) diethylthiambutene;4 (16) dimenoxadol;5 (17) dimepheptanol;6 (18) dimethylthiambutene;7 (19) dioxaphetyl butyrate;8 (20) dipipanone;9 (21) ethylmethylthiambutene;10 (22) etonitazene;11 (23) etoxeridine;12 (24) furethidine;13 (25) hydroxypethidine;14 (26) ketobemidone;15 (27) levomoramide;16 (28) levophenacylmorphan;[bracketed material] = delete17 (29) morpheridine;underscored material = new18 (30) noracymethadol;19 (31) norlevorphanol;20 (32) normethadone;21 (33) norpipanone;22 (34) phenadoxone;23 (35) phenampromide;24 (36) phenomorphan;25 (37) phenoperidine;.232205.1- 4 -1 (38) piritramide;2 (39) proheptazine;3 (40) properidine;4 (41) racemoramide; and5 (42) trimeperidine;6 B. any of the following opium derivatives, their7 salts, isomers and salts of isomers, unless specifically8 exempted, whenever the existence of these salts, isomers and9 salts of isomers is possible within the specific chemical10 designation:11 (1) acetorphine;12 (2) acetyldihydrocodeine;13 (3) benzylmorphine;14 (4) codeine methylbromide;15 (5) codeine-N-oxide;16 (6) cyprenorphine;[bracketed material] = delete17 (7) desomorphine;underscored material = new18 (8) dihydromorphine;19 (9) etorphine;20 (10) heroin;21 (11) hydromorphinol;22 (12) methyldesorphine;23 (13) methyldihydromorphine;24 (14) morphine methylbromide;25 (15) morphine methylsulfonate;.232205.1- 5 -1 (16) morphine-N-oxide;2 (17) myrophine;3 (18) nicocodeine;4 (19) nicomorphine;5 (20) normorphine;6 (21) pholcodine; and7 (22) thebacon;8 C. any material, compound, mixture or preparation9 that contains any quantity of the following hallucinogenic10 substances, their salts, isomers and salts of isomers, unless11 specifically exempted, whenever the existence of these salts,12 isomers and salts of isomers is possible within the specific13 chemical designation:14 (1) 3,4-methylenedioxy amphetamine;15 (2) 5-methoxy-3,4-methylenedioxy amphetamine;16 (3) 3,4,5-trimethoxy amphetamine;[bracketed material] = delete17 (4) bufotenine;underscored material = new18 (5) diethyltryptamine;19 (6) dimethyltryptamine;20 (7) 4-methyl-2,5-dimethoxy amphetamine;21 (8) ibogaine;22 (9) lysergic acid diethylamide;23 (10) mescaline;24 (11) peyote, except as otherwise provided in25 the Controlled Substances Act;.232205.1- 6 -1 (12) N-ethyl-3-piperidyl benzilate;2 (13) N-methyl-3-piperidyl benzilate;3 (14) psilocybin, except as provided otherwise4 in the Controlled Substances Act and the Medical Psilocybin Act5 and except for federal food and drug administration-approved6 synthetic psilocybin or -approved drugs that contain synthetic7 psilocybin;8 (15) psilocin, except as provided otherwise in9 the Controlled Substances Act and the Medical Psilocybin Act;10 (16) synthetic cannabinoids, including:11 (a) 1-[2-(4-(morpholinyl)ethyl]12 -3-(1-naphthoyl)indole;13 (b) 1-butyl-3-(1-napthoyl)indole;14 (c) 1-hexyl-3-(1-naphthoyl)indole;15 (d) 1-pentyl-3-(1-naphthoyl)indole;16 (e) 1-pentyl-3-(2-methoxyphenylacetyl)[bracketed material] = delete17 indole;underscored material = new18 (f) cannabicyclohexanol (CP 47, 497 and19 homologues: 5-(1,1-dimethylheptyl)-2-[(1R,3S)20 -3-hydroxycyclohexyl]-phenol (CP-47,497); and 5-(1,21 1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol;22 (g) 6aR,10aR)-9-(hydroxymethyl)23 -6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,24 10a-tetrahydrobenzo[c]chromen-1-ol);25 (h) dexanabinol, (6aS,10aS).232205.1- 7 -1 -9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)2 -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;3 (i) 1-pentyl-3-(4-chloro naphthoyl)4 indole;5 (j) (2-methyl-1-propyl-1H-indol-3-yl)6 -1-naphthalenyl-methanone; and7 (k) 5-(1,1-dimethylheptyl)-2-(3-hydroxy8 cyclohexyl)-phenol;9 (17) 3,4-methylenedioxymethcathinone;10 (18) 3,4-methylenedioxypyrovalerone;11 (19) 4-methylmethcathinone;12 (20) 4-methoxymethcathinone;13 (21) 3-fluoromethcathinone; and14 (22) 4-fluoromethcathinone;15 D. the enumeration of peyote as a controlled16 substance does not apply to the use of peyote in bona fide[bracketed material] = delete17 religious ceremonies by a bona fide religious organization, andunderscored material = new18 members of the organization so using peyote are exempt from19 registration. Any person who manufactures peyote for or20 distributes peyote to the organization or its members shall21 comply with the federal Comprehensive Drug Abuse Prevention and22 Control Act of 1970 and all other requirements of law;23 E. the enumeration of psilocybin and psilocin in24 this schedule does not apply to their medical use as provided25 in the Medical Psilocybin Act;.232205.1- 8 -1 F. the enumeration of Schedule I controlled2 substances does not apply to:3 (1) hemp pursuant to rules promulgated by the4 board of regents of New Mexico state university on behalf of5 the New Mexico department of agriculture;6 (2) cultivation of hemp by persons pursuant to7 rules promulgated by the board of regents of New Mexico state8 university on behalf of the New Mexico department of9 agriculture;10 (3) tetrahydrocannabinols or chemical11 derivatives of tetrahydrocannabinols, including12 tetrahydrocannabinols or chemical derivatives of13 tetrahydrocannabinols with concentrations of up to five percent14 as measured using a post-decarboxylation method and based on15 percentage dry weight, possessed by a person in connection with16 the cultivation, transportation, testing, researching,[bracketed material] = delete17 manufacturing or other processing of the plant Cannabis sativaunderscored material = new18 L., or any part of the plant whether growing or not, if19 authorized pursuant to rules promulgated, pursuant to the Hemp20 Manufacturing Act, by the board of regents of New Mexico state21 university on behalf of the New Mexico department of22 agriculture or the department of environment; or23 (4) tetrahydrocannabinols or chemical24 derivatives of tetrahydrocannabinols, including25 tetrahydrocannabinols or chemical derivatives of.232205.1- 9 -1 tetrahydrocannabinols in any concentration possessed by a2 person in connection with the extraction of3 tetrahydrocannabinols or chemical derivatives of4 tetrahydrocannabinols, if authorized pursuant to rules5 promulgated, pursuant to the Hemp Manufacturing Act, by the6 board of regents of New Mexico state university on behalf of7 the New Mexico department of agriculture or the department8 of environment; and9 G. controlled substances added to Schedule I by10 rule adopted by the board pursuant to Section 30-31-3 NMSA11 1978."12 - 10 -13141516[bracketed material] = delete17underscored material = new1819202122232425.232205.1
Use Of Fda-approved Psilocybin
Sponsors
Rep. Dayan Hochman-Vigil (D) sponsors HB 336 alone.
History
HB 336 has taken 2 actions since Feb 4, 2026.
| Chamber | Action | |||
|---|---|---|---|---|
Feb 4, 2026 | House | Not Printed | ||
Feb 4, 2026 | House | Action Postponed Indefinitely |
Votes
HB 336 has not gone to a roll call.
Source: nmlegis.gov · legiscan.com